RECOMMENDATION FOR AN EMERGENCY USE LISTING OF COVID-19 VACCINE JANSSEN SUBMITTED BY Janssen – Cilag International N. V. (Belg
Johnson & Johnson Unveils New Vaccines Launch Facility in Holland
AMENDMENT OF SOLICITATIONAVIODIFICATION OF CONTRACT I 89
COVID-19 Vaccine Janssen, INN-Ad26.COV2-S, recombinant
J&J working with Beth Israel to accelerate COVID-19 vaccine developmen
Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19
Janssen-Impfstoff: Starterkit für Apotheken | APOTHEKE ADHOC
COVID-19-Impfstoff: Johnson & Johnson beantragt Zulassung in Europa und den USA | BIO.NRW
Johnson & Johnson gibt die Zustimmung der Europäischen Kommission zu Vertrag über die Lieferung von 200 Millionen Dosen des COVID-19-Impfstoffkandidaten von Janssen bekannt
COVID-19 Vaccine Janssen, INN-Ad26.COV2-S, recombinant
Maintaining Safety with SARS-CoV-2 Vaccines | NEJM
COVID-19 Vaccine Could Cost As Little As $10 A Dose, Says Janssen :: Scrip
Neue Studienergebnisse: RSV-Impfung schützt zu 80 Prozent - PTAheute
J&J Seeks EUA for COVID-19 Vaccine
Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
130 years of vaccine know-how
Johnson & Johnson 'Pauses' COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment - Health Policy Watch
La plateforme AdVac® de Janssen
Johnson & Johnson Announces Donation of up to 500,000 Regimens of Janssen's Investigational Ebola Vaccine to Support Outbreak Response in Democratic Republic of the Congo (DRC)
Coronavirus: the Commission approves third contract to ensure access to a potential vaccine
Johnson & Johnson Announces Donation of up to 500,000 Regimens of Janssen's Investigational Ebola Vaccine to Support Outbreak Response in Democratic Republic of the Congo (DRC)
Impfstoffentwicklung: Mosaikvakzine gegen HIV erprobt
Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
Janssen sieht Auslieferung für Anfang 2021 | APOTHEKE ADHOC
